chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Varicella Information received from a physician and a licensed practical nurse (LPN) concerning a 10 year old white male student with no medical history who on 05-SEP-1996 was vaccinated SC in the left arm with a second dose of varicella virus vaccine live (Oka/Merck) (Lot#608666/0392B). There was no illness at the time of vaccination. It was reported that 07-FEB-2006 the patient developed chickenpox. On 08-FEB-2006, the patient presented to the physician's office with chickenpox characterized by approximately 20 lesions along with multiple papules and vesicles. At that time, some crusting of the vesicles was noted but the patient was also noted to be still breaking out with lesions. No laboratory/diagnostic tests were performed. Subsequently the patient's chickenpox resolved. Additional information is not expected.
Extreme joint pain consistent with rheumatoid arthritis from shoulders down to my feet; extreme joint pain consistent with rheumatoid arthritis from shoulders down to my feet; Plantar fasciitis; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in left arm on 02Apr2021 11:00 AM (at the age of 50-years-old) at dose 1, single for COVID-19 immunisation. The patient was not pregnant. Medical history included COVID prior vaccination, asthma and allergies. Concomitant medications included escitalopram oxalate (LEXAPRO) taken at 10mg, budesonide, formoterol fumarate (SYMBICORT); both reported as other medications in two weeks. No other vaccine received in four weeks. The patient experienced extreme joint pain consistent with rheumatoid arthritis from shoulders down to her feet on 07Apr2021. This lasted for 6-8 weeks. She was taking ibuprofen 3 times per day to make sitting and standing comfortable. The symptoms eventually went away but she still had plantar fasciitis from 07Apr2021. Events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures, which included COVID tested post vaccination on 22Sep2021 via nasal swab: negative. No treatment was received for plantar fasciitis. The patient recovered with sequel from extreme joint pain consistent with rheumatoid arthritis from shoulders down to her feet in 2021, had not recovered from plantar fasciitis.   The lot number for BNT162B2 was not provided and will be requested during follow up.
After 7 weeks / arm still hurts; This case was reported by a other health professional via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 2 months after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were provided are as follows: The age at vaccination was not reported. The reporter reported that, the patient of him/her got the shingles shot in unknown arm and after 7 weeks their arm still hurts. The follow up would not be possible as no contact details were available.
pt states after receiving vaccine about one minute after pt states she felt arm tingling and pins and needles feeling in left  arm and metallic taste in mouth, and very anxious  pt shaking and was unable to sit still in stretcher, refused wheelchair to observation area and ambulated self without difficutly.  pt also very guarded and did not want to talk about health history or meds upon assessment.  pt state feeling hot and cold chills as well. pt anxious about previous anaphylaxis had in past with darvocet. denies feeling symtpoms of anaphylaxis, site of injection healthy  no observed hives or redness in area.  vs as noted, pt  feeling better and wanting to be sent home  pt ambulated to exit with husband at 1438 vs: 1410 bp123/81 hr 84 rr 18 o2 97  1415 bp 140/96 rr 18 hr 78 o2 98  1420 bp 137/80 hr 80 rr 18 o298  1425 131/89 hr 80 rr 18 o2 99
Site: Pain at Injection Site-Mild, Additional Details: Right after immunization pt stated that she had a numbing/tingling feeling on the arm. I told pt that it might be due to needle accidentally touching a nerve, and that I will call in a few hours to follow up. After a few hours when I called pt, she stated that it was not a numbing feeling, there is pain around injection site, though. I offered pt to call her primary care and/or call her back to check on her in a few hours later during the day. Pt stated that further follow up is not necessary.
Second Shingrix shot. Arm swollen and red. Shivering during the night. Severe headache. Upset stomach and diarrhea.
Brain disorder; loud noises from inside the brain; Started getting tinnitus, which was pretty bad; This spontaneous case was reported by a patient and describes the occurrence of CEREBRAL DISORDER (Brain disorder), HEAD DISCOMFORT (loud noises from inside the brain) and TINNITUS (Started getting tinnitus, which was pretty bad) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041A21A and 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced TINNITUS (Started getting tinnitus, which was pretty bad). On 18-Sep-2022, the patient experienced CEREBRAL DISORDER (Brain disorder) and HEAD DISCOMFORT (loud noises from inside the brain). At the time of the report, CEREBRAL DISORDER (Brain disorder) and HEAD DISCOMFORT (loud noises from inside the brain) outcome was unknown and TINNITUS (Started getting tinnitus, which was pretty bad) had not resolved.            Patient's height was reported as 5'6. Patient had never tested COVID-19 positive. No other vaccines were given 1 month prior to Moderna Vaccine. No concomitant medications was reported.  It was reported that the patient did not wanted to get anymore booster doses as the patient had side effects after the second vaccination. Patient started getting Tinnitus almost exactly 2 weeks after vaccination, it was bad. In the day time, patient had to play the TV loudly to cover the sounds inside head. It was an electronic, static-y type of sound. The patient had to sleep with loud music, it was awful. The patient went to nurses and doctors. It was like a hypochondriac, had never been one. The event came and go, it started getting back in last three weeks with different intensity. On 18-Sep-2022 night, It was in left ear only, Patient reported it as brain disorder, It had loud noises form inside the brain. Patient did not seek any medical care for events.  No treatment medications was reported.
DIZZY, NAUSEA, ELEVATED BP , LOW BLOOD SUGAR     GAVE PEANUT BUTTER AND CRACKERS AND ENCOURAGED PT TO DRINK HER  BOTTLE OF SWEET TEA THAT SHE HAD WITH HER.  ADVISED PT TO SEEK IMMEDIATE CARE
pt recvd vax in AM pt cried from 1PM till 3PM & again from 6PM to 10PM; inconsable;
Patient developed a progressing diffuse non-raised erythema based rash  that started on left arm (vaccine arm) and progressed to entire body, excluding face and head. Mild pruritic, no blistering. No oral mucosa changes, no burning with urination, no n/v/d or cp, sob, or abd pain.  Steroid injection, solumedrol mg IM x 1 in clinic, medrol dose pak and hydroxyzine upon d/c home.
Information has been received from a healthcare worker concerning a patient of unknown age and gender. There was no pertinent medical history or drug reactions/allergies reported. On 03-AUG-2015 the patient was vaccinated with an improperly stored ROTATEQ (lot number K008212 and expiration date: 30-SEP-2015). No adverse effect reported. Additional information has been requested.
Administrative error.  Administered 0.5ml dose instead of 0.5mg or .25ml.   No adverse symptoms from patient or complaints.
Bottom of feet started tingling/itching around 8pm. Continued itching on feet and legs started itching at 11pm. Around 11pm I noticed hives forming on my ankles and legs. I called oncall physician and was directed to take BENADRYL. Took BENADRYL but hives continued to spread up my legs/thighs. I was very warm and heart racing. Admitted myself into the ER around 12am on 10/3/2012. Hives continued to spread to my arms while waiting for treatment in the ER. ER administered (3) prednisone tablets, (1) unknown pill and a shot in my arm. Left hospital around 2am. Rash started to dimisnish about 30 minutes after receiving treatment at the hospital. Remained weak and ill 10/3/2012-10/5/2012.
Sudden development of hot flashes with sweating and blurry vision- felt like I was going to faint.; Sudden development of hot flashes with sweating and blurry vision- felt like I was going to faint.; Sudden development of hot flashes with sweating and blurry vision- felt like I was going to faint.; Sudden development of hot flashes with sweating and blurry vision- felt like I was going to faint.; Tingly sensation in arms and then some nausea and general feeling of weakness with persistent headache.; Tingly sensation in arms and then some nausea and general feeling of weakness with persistent headache.; Tingly sensation in arms and then some nausea and general feeling of weakness with persistent headache.; Tingly sensation in arms and then some nausea and general feeling of weakness with persistent headache.; This is a spontaneous report from a contactable nurse.  A 28-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), Lot number= ELO140, via an unspecified route of administration, in the right arm, on 31Dec2020 at 13:45 (at the age of 28 years-old) as a single dose for COVID-19 immunization. The vaccine was administered at a hospital. Medical history included polycystic ovarian syndrome. There were no concomitant medications. The patient had not received other vaccines in 4 weeks nor taken any other medications in 2 weeks. Prior to the vaccination the patient was not diagnosed with COVID-19. On 01Jan2021 at 0700 the patient experienced hot flashes with sweating and blurry vision- felt like she was going to faint, tingly sensation in arms and then some nausea and general feeling of weakness with persistent headache. The clinical course was as follows: Sudden development of hot flashes with sweating and blurry vision- felt like she was going to faint, tingly sensation in arms and then some nausea and general feeling of weakness with persistent headache. The vision blurring and hot flashes resolved within 15-20 minutes but the fatigue, headache and nausea persisted throughout the day. The patient was not hospitalized for the event nor was treatment administered. The clinical outcome of the hot flashes with sweating and blurry vision- felt like she was going to faint, tingly sensation in arms and then some nausea and general feeling of weakness with persistent headache. Since the vaccination, the patient has not been tested for COVID-19.
This spontaneous report as received from a consumer regarding her granddaughter a 17 year old female patient with AUGMENTIN allergy. In the middle of October 2013, patient receive her first dose of GARDASIL (dose, concentration, and lot number not reported). On 18-NOV-2013, the patient was vaccinated with her second dose of GARDASIL (dose, concentration and lot number not provided). No concomitant therapy was reported. Approximately on November 2013, the patient experienced headache after received the second shot of GARDASIL. The reporter stated that the patient has not yet received a third shot of GARDASIL. The outcome of headache was unknown. Additional information has been requested.
vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 002A24A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021 at 1:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 02-Jun-2021. On 27-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy). On 24-Feb-2021, EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) had resolved.            Date of positive pregnancy test 24-SEP-2021  The action taken with mRNA-1273(Moderna COVID-19 Vaccine) was not applicable  No concomitant medications were reported  No treatment drugs were reported
Per patient, she had a rash on her one side of her abdomen. She went to her doctor when the rash was still present after 3 days. But her doctor did not know what it was per the patient. It has cleared since. This was not observed by the pharmacy.
The pain is now down a little bit further in his back.; Neck pain which has continued up to today and is worsening; This spontaneous case was reported by a pharmacist and describes the occurrence of NECK PAIN (Neck pain which has continued up to today and is worsening) and BACK PAIN (The pain is now down a little bit further in his back.) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 071F21A, 025J20A and 025J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced NECK PAIN (Neck pain which has continued up to today and is worsening). On 06-Dec-2021, the patient experienced BACK PAIN (The pain is now down a little bit further in his back.). The patient was treated with IBUPROFEN at a dose of 1 UNK and PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, NECK PAIN (Neck pain which has continued up to today and is worsening) and BACK PAIN (The pain is now down a little bit further in his back.) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product was provided by the reporter.  Patient had minimal relief after taking ibuprofen and tylenol for the pain but has not helped significantly.
He was sick; he was super sore; He did not receive the second one because he didn't want to have further reactions; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (He was sick), MYALGIA (he was super sore) and PRODUCT DOSE OMISSION ISSUE (He did not receive the second one because he didn't want to have further reactions) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (He was sick), MYALGIA (he was super sore) and PRODUCT DOSE OMISSION ISSUE (He did not receive the second one because he didn't want to have further reactions). At the time of the report, ILLNESS (He was sick) and MYALGIA (he was super sore) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (He did not receive the second one because he didn't want to have further reactions) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were provided. No treatments were provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Aug-2021: Reporter details, Patient details, Product Start date, Batch no. were added and new events Myalgia and Illness were added.
Injection site soreness that lasted about 36 hours. fatigue that started the next day and lasted about 24 hours. Intermittent hip joint pain that was very sharp and lasts about 4 to 5 seconds. This started about 24 hours after the second injection.  It is still ongoing 2 days after the second injection. This is an infrequent pain and does not affect my ability to go about my normal routine.
Broke out with hives all over Body, extreme Joint swelling,  with in 48 hours of shot started to feel skin problems Went to primary 3 times they sent me to Dr put me on prednisone the went to Dr had Biop done came Back as dermatitis.
He started with fever and chills on the evening of the day he received the vaccine, Also severe pain in lower sternum, emesis \over the next 2-3 days developed abd pain of lower abd, cough, resp distress, waves of fatigue and hyperventilation, on 5/10 noted full body rash which was itchy, last fever was on 5/13/21, on 5/12 had blood shot eyes, 5/14 - peely skin on palms and face and felt thightness in face
Fatigue, headache, chills, injection site pain. Symptoms subsided about 36 hour post administration of dose.
Patient describes had swelling, hot and redness to injection site and was see at Emergency Room at Medical Center on 8/05/22. Per patient was discharged with Keflex 500mg and advised to take 1 every 8 hours, and states had noticed improvement since started but felt had reached a "roadblock in the healing process". Patient stated continued with some mild swelling injection site appears to be looking like a bruise and there was pain to the touch, pain described as a 5/10 in pain scale.
Pt vaccinated with DTP/OPV experienced inconsolable screaming which became worse through the night and into next day.
tested positive for covid19/diagnosed with Covid; tested positive for covid19/diagnosed with Covid; she had SOB the day of her first vaccination; I am very sick; I feel bad; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration on 21Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the first dose of COVID-19 vaccine on Monday, 21Dec2020 and then was diagnosed with COVID-19 on 23Dec2020. Added that she was very sick and wondering if he'll get her second dose or not. The patient feel bad and is due for her second dose on 11Jan2021. The patient also reported that she had shortness of breath (SOB) the day of her first vaccination on 21Dec2020 and then tested positive for COVID-19 later. She posits she may have received the vaccine when she had an active COVID-19 infection. She is wondering if she can still get her second vaccination. Outcome of the events was unknown.
Information has been received from a pharmacist referring to a patient of unknown age and gender. The patient's concurrent or historical condition was not provided. On 21-JUN-2016 the patient was inadvertently given a dose of M-M-R II (dose, route, lot # and expired date unknown) that was reconstituted with and unspecified amount of sodium chloride rather than the sterile diluent that was supplied with M-M-R II. Concomitant therapy was not provided. No adverse effects reported. Additional information had been requested.
Patient presented rash and tremor in the hands upon arriving home after vaccination. Mother bought him PO BENADRYL and he is taking it every 6 hrs. Yesterday he stopped taking it and the rash returned. Consulted with the Pediatrician who indicated to continue treatment for two more days. Recommended visiting the ER if symptoms worsen.
pallor w/diaphoresis, cool, lipothymia rxn;BP remained @ 100/70-110/80;pulse regular 76-82;appeared very nervous (nail biting); laid in exam room w/father;cool compresses;juice/H20;reassurance;
Diffuse hives, mild respiratory distress/wheezing, limp, mild facial swelling. The medical record states, anaphylaxis is confirmed. Diagnosis: anaphylaxis secondary to Trihibit vaccination.
pt recvd vax & began having sz; pt taken to hosp & MD said pt should not recv vax containing pertussis;
Scheduled to receive a Tdap vaccine at school vaccine clinic by Health Department (HD) nurses. School nurse had given HD nurses of the students signed up needing the vaccine. I gave the vaccine on 10/18/22 and our secretary was entering it on Immunization Registry and saw it had been given 07/05/2022. NO adverse effects.--I did talk with school nurse regarding her process . (e-mail had been sent to all 6th graders that Tdaps were offered in the schools when HD comes to give Flu vaccines. Mother thought that meant her child needed it so she completed a form for this child. Process will change next year) I also phoned her doctor's office and he stated should not have issues. Reported this to mother. (I had already reported to just expect intensified side affects).
Information has been received from a physician concerning a 6 month old male patient who on 06-JAN-2009 was vaccinated with one dose of ROTATEQ. It was reported that on 09-MAR-2009 the patient was diagnosed with rotavirus. The patient sought medical attention via office visit. The outcome of the patient was unknown. Follow-up information has been from a registered nurse in the physician's office concerning the 18 week old male patient who on 06-JAN-2009 was vaccinated with the first dose of ROTATEQ (lot # 662654/1356X). Vaccine received at the same day included DAPTACEL (lot # C3000AA) into his right thigh, ACTHIB (lot #: UF519AA) into his right thigh, IPOL (lot #: A1229) into his left thigh and PREVNAR (lot #: C45721H) into his right thigh. On 08-MAR-2009 the patient experienced diarrhea and vomiting and was taken to emergency room. The primary diagnoses was acute gastroenteritis. On 08-MAR-2009, stool rotavirus antigen test was performed, which was positive for rotavirus antigen. The patient was hospitalized with rotavirus for 8 days. On 08-MAR-2009, wright stain for white blood cell (WBC) and red blood cell (RBC) on stool was performed, segs, Lymphocytes, eosinophil and red blood cell were not seen. On 08-MAR-2009, other lab test performed included respiratory syncytial virus (RSV) in nasopharyngeal wash negative, influenza A and B antigen in nasal swab negative, stool campylobacter smear negative and stool SHIGA-LIKE toxin assay showed negative for SHGA toxin-producing E. coli. Stool culture was performed on 08-MAR-2009, the result on 10-MAR-2009 revealed normal enteric flora, no salmonella or shigella isolated and no campylobacter isolated. On 13-MAR-2009, stool rotavirus was still positive and stool culture was negative. The patient recovered from rotavirus/acute gastroenteritis. Follow-up information received on 11-JUN-2009 contained the following adverse experience: Upper respiratory infection (08-MAR-2009). Additional information has been requested. All available medical records will be provided upon request.
After receiving vaccine, displayed tenderness and redness at injection site.  Within a few days after receiving vaccine, displayed flu like symptoms, tightness in right arm, soreness through right arm, inability to use full range of motion.  Patient was also vaccinated with Gammaglobulin at the time the Anthrax vaccine was administered.  The Gammaglobulin vaccine was administered in patients right hip / buttock area.